Potential Interaction Between SARS-CoV-2 and Thyroid: A Review
The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although much has been learned about the clinical course, prognostic inflammatory markers, and disease complications of COVID-19, the pot...
Gespeichert in:
| Veröffentlicht in: | Endocrinology (Philadelphia) 2021-03, Vol.162 (3) |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 3 |
| container_start_page | |
| container_title | Endocrinology (Philadelphia) |
| container_volume | 162 |
| creator | Chen, Wenjie Tian, Yuang Li, Zhihui Zhu, Jingqiang Wei, Tao Lei, Jianyong |
| description | The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although much has been learned about the clinical course, prognostic inflammatory markers, and disease complications of COVID-19, the potential interaction between SARS-CoV-2 and the thyroid is poorly understood. In contrast to SARS-CoV-1, limited available evidence indicates there is no pathological evidence of thyroid injury caused by SARS-CoV-2. However, subacute thyroiditis caused by SARS-CoV-2 has been reported for the first time. Thyroid dysfunction is common in patients with COVID-19 infection. By contrast, certain thyroid diseases may have a negative impact on the prevention and control of COVID-19. In addition, some anti-COVID-19 agents may cause thyroid injury or affect its metabolism. COVID-19 and thyroid disease may mutually aggravate the disease burden. Patients with SARS-CoV-2 infection should not ignore the effect on thyroid function, especially when there are obvious related symptoms. In addition, patients with thyroid diseases should follow specific management principles during the epidemic period. |
| doi_str_mv | 10.1210/endocr/bqab004 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7953946</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33543236</sourcerecordid><originalsourceid>FETCH-LOGICAL-p786-82b0ff83402e1cc371d89f8825c9289b6b9f794a3daff83824a4f19c2601e2df3</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMotla3LiV_IDavmSQuCuPgo1BQ2uJ2yORhI20yTqct_fdWfKCrw-Ge83E5AFwSfE0owUMXbTLtsH7XNcb8CPSJ4hkSROBj0MeYMCQoFT1wtl6_HSznnJ2CHmMZZ5TlfTB6Tp2LXdBLOI6da7XpQorw1nU75yKcFdMZKtMLolBHC-eLfZuCvYEFnLptcLtzcOL1cu0uvnUA5vd38_IRTZ4exmUxQY2QOZK0xt5LxjF1xBgmiJXKS0kzo6hUdV4rLxTXzOrPmKRcc0-UoTkmjlrPBmD0hW029cpZc_i41cuqacNKt_sq6VD9v8SwqF7TthIqY4rnB8DVX8Bv82cI9gHRtGDb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Potential Interaction Between SARS-CoV-2 and Thyroid: A Review</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Chen, Wenjie ; Tian, Yuang ; Li, Zhihui ; Zhu, Jingqiang ; Wei, Tao ; Lei, Jianyong</creator><creatorcontrib>Chen, Wenjie ; Tian, Yuang ; Li, Zhihui ; Zhu, Jingqiang ; Wei, Tao ; Lei, Jianyong</creatorcontrib><description>The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although much has been learned about the clinical course, prognostic inflammatory markers, and disease complications of COVID-19, the potential interaction between SARS-CoV-2 and the thyroid is poorly understood. In contrast to SARS-CoV-1, limited available evidence indicates there is no pathological evidence of thyroid injury caused by SARS-CoV-2. However, subacute thyroiditis caused by SARS-CoV-2 has been reported for the first time. Thyroid dysfunction is common in patients with COVID-19 infection. By contrast, certain thyroid diseases may have a negative impact on the prevention and control of COVID-19. In addition, some anti-COVID-19 agents may cause thyroid injury or affect its metabolism. COVID-19 and thyroid disease may mutually aggravate the disease burden. Patients with SARS-CoV-2 infection should not ignore the effect on thyroid function, especially when there are obvious related symptoms. In addition, patients with thyroid diseases should follow specific management principles during the epidemic period.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/endocr/bqab004</identifier><identifier>PMID: 33543236</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Comorbidity ; COVID-19 - complications ; COVID-19 - drug therapy ; COVID-19 - epidemiology ; Female ; Heparin, Low-Molecular-Weight - therapeutic use ; Humans ; Male ; Mini-Reviews ; SARS-CoV-2 ; Thyroid Diseases - epidemiology ; Thyroid Diseases - physiopathology ; Thyroid Diseases - therapy ; Thyroid Gland - drug effects ; Thyroid Gland - physiopathology ; Thyroid Gland - virology ; Thyroiditis - virology ; Thyrotropin - blood ; Triiodothyronine - therapeutic use</subject><ispartof>Endocrinology (Philadelphia), 2021-03, Vol.162 (3)</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33543236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Wenjie</creatorcontrib><creatorcontrib>Tian, Yuang</creatorcontrib><creatorcontrib>Li, Zhihui</creatorcontrib><creatorcontrib>Zhu, Jingqiang</creatorcontrib><creatorcontrib>Wei, Tao</creatorcontrib><creatorcontrib>Lei, Jianyong</creatorcontrib><title>Potential Interaction Between SARS-CoV-2 and Thyroid: A Review</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although much has been learned about the clinical course, prognostic inflammatory markers, and disease complications of COVID-19, the potential interaction between SARS-CoV-2 and the thyroid is poorly understood. In contrast to SARS-CoV-1, limited available evidence indicates there is no pathological evidence of thyroid injury caused by SARS-CoV-2. However, subacute thyroiditis caused by SARS-CoV-2 has been reported for the first time. Thyroid dysfunction is common in patients with COVID-19 infection. By contrast, certain thyroid diseases may have a negative impact on the prevention and control of COVID-19. In addition, some anti-COVID-19 agents may cause thyroid injury or affect its metabolism. COVID-19 and thyroid disease may mutually aggravate the disease burden. Patients with SARS-CoV-2 infection should not ignore the effect on thyroid function, especially when there are obvious related symptoms. In addition, patients with thyroid diseases should follow specific management principles during the epidemic period.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Comorbidity</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - drug therapy</subject><subject>COVID-19 - epidemiology</subject><subject>Female</subject><subject>Heparin, Low-Molecular-Weight - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Mini-Reviews</subject><subject>SARS-CoV-2</subject><subject>Thyroid Diseases - epidemiology</subject><subject>Thyroid Diseases - physiopathology</subject><subject>Thyroid Diseases - therapy</subject><subject>Thyroid Gland - drug effects</subject><subject>Thyroid Gland - physiopathology</subject><subject>Thyroid Gland - virology</subject><subject>Thyroiditis - virology</subject><subject>Thyrotropin - blood</subject><subject>Triiodothyronine - therapeutic use</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLAzEUhYMotla3LiV_IDavmSQuCuPgo1BQ2uJ2yORhI20yTqct_fdWfKCrw-Ge83E5AFwSfE0owUMXbTLtsH7XNcb8CPSJ4hkSROBj0MeYMCQoFT1wtl6_HSznnJ2CHmMZZ5TlfTB6Tp2LXdBLOI6da7XpQorw1nU75yKcFdMZKtMLolBHC-eLfZuCvYEFnLptcLtzcOL1cu0uvnUA5vd38_IRTZ4exmUxQY2QOZK0xt5LxjF1xBgmiJXKS0kzo6hUdV4rLxTXzOrPmKRcc0-UoTkmjlrPBmD0hW029cpZc_i41cuqacNKt_sq6VD9v8SwqF7TthIqY4rnB8DVX8Bv82cI9gHRtGDb</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Chen, Wenjie</creator><creator>Tian, Yuang</creator><creator>Li, Zhihui</creator><creator>Zhu, Jingqiang</creator><creator>Wei, Tao</creator><creator>Lei, Jianyong</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>20210301</creationdate><title>Potential Interaction Between SARS-CoV-2 and Thyroid: A Review</title><author>Chen, Wenjie ; Tian, Yuang ; Li, Zhihui ; Zhu, Jingqiang ; Wei, Tao ; Lei, Jianyong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p786-82b0ff83402e1cc371d89f8825c9289b6b9f794a3daff83824a4f19c2601e2df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Comorbidity</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - drug therapy</topic><topic>COVID-19 - epidemiology</topic><topic>Female</topic><topic>Heparin, Low-Molecular-Weight - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Mini-Reviews</topic><topic>SARS-CoV-2</topic><topic>Thyroid Diseases - epidemiology</topic><topic>Thyroid Diseases - physiopathology</topic><topic>Thyroid Diseases - therapy</topic><topic>Thyroid Gland - drug effects</topic><topic>Thyroid Gland - physiopathology</topic><topic>Thyroid Gland - virology</topic><topic>Thyroiditis - virology</topic><topic>Thyrotropin - blood</topic><topic>Triiodothyronine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Wenjie</creatorcontrib><creatorcontrib>Tian, Yuang</creatorcontrib><creatorcontrib>Li, Zhihui</creatorcontrib><creatorcontrib>Zhu, Jingqiang</creatorcontrib><creatorcontrib>Wei, Tao</creatorcontrib><creatorcontrib>Lei, Jianyong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Wenjie</au><au>Tian, Yuang</au><au>Li, Zhihui</au><au>Zhu, Jingqiang</au><au>Wei, Tao</au><au>Lei, Jianyong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential Interaction Between SARS-CoV-2 and Thyroid: A Review</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>162</volume><issue>3</issue><issn>0013-7227</issn><eissn>1945-7170</eissn><abstract>The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although much has been learned about the clinical course, prognostic inflammatory markers, and disease complications of COVID-19, the potential interaction between SARS-CoV-2 and the thyroid is poorly understood. In contrast to SARS-CoV-1, limited available evidence indicates there is no pathological evidence of thyroid injury caused by SARS-CoV-2. However, subacute thyroiditis caused by SARS-CoV-2 has been reported for the first time. Thyroid dysfunction is common in patients with COVID-19 infection. By contrast, certain thyroid diseases may have a negative impact on the prevention and control of COVID-19. In addition, some anti-COVID-19 agents may cause thyroid injury or affect its metabolism. COVID-19 and thyroid disease may mutually aggravate the disease burden. Patients with SARS-CoV-2 infection should not ignore the effect on thyroid function, especially when there are obvious related symptoms. In addition, patients with thyroid diseases should follow specific management principles during the epidemic period.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>33543236</pmid><doi>10.1210/endocr/bqab004</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0013-7227 |
| ispartof | Endocrinology (Philadelphia), 2021-03, Vol.162 (3) |
| issn | 0013-7227 1945-7170 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7953946 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adrenal Cortex Hormones - therapeutic use Comorbidity COVID-19 - complications COVID-19 - drug therapy COVID-19 - epidemiology Female Heparin, Low-Molecular-Weight - therapeutic use Humans Male Mini-Reviews SARS-CoV-2 Thyroid Diseases - epidemiology Thyroid Diseases - physiopathology Thyroid Diseases - therapy Thyroid Gland - drug effects Thyroid Gland - physiopathology Thyroid Gland - virology Thyroiditis - virology Thyrotropin - blood Triiodothyronine - therapeutic use |
| title | Potential Interaction Between SARS-CoV-2 and Thyroid: A Review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A55%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20Interaction%20Between%20SARS-CoV-2%20and%20Thyroid:%20A%20Review&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Chen,%20Wenjie&rft.date=2021-03-01&rft.volume=162&rft.issue=3&rft.issn=0013-7227&rft.eissn=1945-7170&rft_id=info:doi/10.1210/endocr/bqab004&rft_dat=%3Cpubmed%3E33543236%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33543236&rfr_iscdi=true |